GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenith Capital Corp (OTCPK:ZHCLF) » Definitions » Shares Buyback Ratio %

Zenith Capital (Zenith Capital) Shares Buyback Ratio % : 0.00 (As of Jun. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Zenith Capital Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Zenith Capital's current shares buyback ratio was 0.00%.


Zenith Capital Shares Buyback Ratio % Historical Data

The historical data trend for Zenith Capital's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenith Capital Shares Buyback Ratio % Chart

Zenith Capital Annual Data
Trend
Shares Buyback Ratio %

Zenith Capital Quarterly Data
Shares Buyback Ratio %

Zenith Capital Shares Buyback Ratio % Calculation

Zenith Capital's Shares Buyback Ratio for the fiscal year that ended in . 20 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: . 20 ) - Shares Outstanding (EOP) (A: . 20 )) / Shares Outstanding (EOP) (A: . 20 )
=( - ) /
=N/A%

Zenith Capital's Shares Buyback Ratio for the quarter that ended in . 20 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: . 20 ) - Shares Outstanding (EOP) (A: . 20 )) / Shares Outstanding (EOP) (A: . 20 )
=( - ) /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zenith Capital Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Zenith Capital's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zenith Capital (Zenith Capital) Business Description

Traded in Other Exchanges
N/A
Address
300, 4820 RIchard Road SW, Calgary, AB, CAN, T3E 6L1
Website
Zenith Capital Corp is a biotechnology investment company. The company operates through its wholly-owned subsidiary Zenith Epigenetics Ltd. It is a clinical-stage biotechnology company focused on discovering and developing novel therapeutics. The company is developing various novel combinations of BET inhibitors with other targeted agents. Its lead compound, ZEN-3694, is in clinical development for metastatic Castration Resistant Prostate Cancer (mCRPC) in collaboration with Astellas and Newsoara and in metastatic triple-negative breast cancer.

Zenith Capital (Zenith Capital) Headlines

No Headlines